People with chronic kidney disease not only suffer from the effects of the their body’s inability to flush waste from their systems, but they also face a higher rate of cardiovascular disease. It’s the most common cause of death for people with CKD. Taking fatty acids may help reduce the inflammation that lead to heart disease, according to new research from Australia.
Researchers from the University of Western Australia conducted a randomized, double-blind study with 85 patients with chronic renal failure between the ages of 25 and 75. Groups of patients received either four daily doses of one gram of n-3 fatty acids, coenzyme Q, both supplements or 4 grams of olive oil to serve as a control group, for two months. During the eight weeks, the patients maintained their diet, meds, alcohol intake and physical activity. Researchers took measurements before and after the two months.
The study showed for the first time that supplementing patients with CKD for eight weeks with n-3 fatty acids enhanced the synthesis of specialized pro-resolving lipid mediators--blood factors known to improve inflammation--which helps resolve inflammation, University of Western Australia research fellow Dr. Emilie Mas said in a release. The research supports previous studies that suggest omegas help reduce inflammation in people with healthy kidneys.
“This study suggests that long term n-3 fatty acid supplementation is a potential therapy for limiting the low-grade inflammation that associates with, and exacerbates, the progression of CKD,” Mas said.
Twenty-six million Americans have CKD and millions of others are at increased risk of developing the disease, according to the National Kidney Foundation.